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ABSTRACT
 
Langerhans cells can originate 
 
in vitro
 
 from immature precursors stimulated with granulocyte macrophage-
colony-stimulating factor (GM-CSF), tumour necrosis factor (TNF)-
 
a
 
 and stem cell factor (SCF). We asked
whether these cytokines also control the differentiation state of Langerhans cells within the epidermis and
upon leaving this tissue. We harvested sheets of human epidermis by controlled dispase hydrolysis of
keratomes, cultured them in RPMI and 10% fetal calf serum for 48 h and analysed the sheets and the cells
migrated spontaneously into the medium, most of which were Langerhans cells containing Birbeck granules.
 
1
 
By flow cytometry, the intensity of CD1a expression was reduced quite evenly among Langerhans cells
migrated from sheets within 48 h. The cells in the sheets underwent loss of dendrites, with a significant
reduction in the cell perimeter that was prevented by GM-CSF and TNF-
 
a
 
 together. Either of these cytokines
induced expression of CD18 by cells in the sheets and those in the medium. Moreover, TNF-
 
a
 
 induced
expression of CD54 by cells in the medium, but not by those retained in the sheets, whereas human SCF
induced, dose dependently, expression of CD54 by cells in the sheets, but not from those in the medium.
 
2
 
The proliferation of allogeneic lymphocytes was much higher when stimulating Langerhans cells were
harvested from cultures with any cytokine, rather than from cultures without cytokines. We conclude the
following: (i) GM-CSF and TNF-
 
a
 
 help to maintain full differentiation of Langerhans cells within the
epidermis; (ii) cytokine influence on Langerhans cells adhesiveness is in part context dependent; and
(iii) pretreatment with cytokines influences positively the number or accessory activity of Langerhans cells
on lymphocytes during subsequent mixed leucocyte reaction.
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Introduction
 
Langerhans cells are part of a widely distributed system of
dendritic cells specialized in antigen presentation. Resident
epidermal Langerhans cells derive from CD34-positive myeloid
precursors and their differentiation can be induced by many
cytokines, including granulocyte-macrophage colony-stimulating
factor (GM-CSF),
 
1,2
 
 tumour necrosis factor (TNF)-
 
a
 
2,3
 
 and
stem cell factor (SCF).
 
4,5
 
 Langerhans cells are highly efficient in
capturing and processing antigens; once loaded with antigens,
they migrate out of the epidermis towards draining lymph
nodes and in the meantime undergo a further differentiation
step, by which they acquire a strong lymphocyte stimulating
activity.
 
6,7
 
 Although this step is often indicated as ‘maturation’,
it is regulated by extrinsic clues and involves deep, irreversible
changes in fine structure and antigen expression; therefore, it is
in proper sense a process of differentiation.
 
8
 
GM-CSF is a monomeric, globular glycoprotein;
 
9
 
 it can be
secreted by lymphocytes even in basal conditions and by many
cell types upon stimulation; the latter include macrophages,
endothelial cells, epithelial cells and fibroblasts.
 
10
 
 This cytokine
has been described to play a key part in the generation and
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viability of Langerhans cells 
 
in vitro
 
 and in the enhancement of
their stimulatory capacity in a mixed leucocyte reaction.
 
2,11
 
TNF-
 
a
 
 is an acidic, unglycosylated protein; it is produced by
monocytes/macrophages and other non-haematopoietic cell
types, after appropriate stimulation.
 
12
 
 This cytokine is also effi-
cient in promoting the generation and maintaining the viability
of Langerhans cells in culture.
 
2,3,13
 
 The addition of GM-CSF and
TNF-
 
a
 
 to cultures of CD34-positive precursors, in the presence
of serum, induces the differentiation of precursors into cells dis-
playing the morphology and immunophenotype of Langerhans
cells, including the presence of Birbeck granules and the expres-
sion of CD1a along with class II major histocompatibility complex
molecules. The CD1a-positive cells harvested from cultures
treated with GM-CSF and TNF-
 
a
 
 induce a strong proliferation
of allogeneic CD4-positive T cells in mixed leucocyte reac-
tion,
 
2,3
 
 although an inhibitory effect of this cytokine on tumour
antigen presentation by Langerhans cells has been reported.
 
14
 
Stem cell factor is a glycoprotein, synthesized as a trans-
membrane protein and produced by bone marrow stromal cells,
T cells, keratinocytes, dermal cells and other cell types as well.
The effects of this cytokine are mediated by a specific receptor,
named c-kit, that has been recognized as a proto-oncogene
before the identification of its ligand, SCF.
 
15
 
 SCF has many
biological activities, among which the ability to stimulate the
proliferation of early haematopoietic progenitors.
 
4
 
 In associ-
ation with GM-CSF and TNF-
 
a
 
, SCF is able to augment the
number of Langerhans and other dendritic cells obtained
 
in vitro
 
, while not affecting the morphological and immuno-
phenotypical characteristics of such cells.
 
4,5,16–18
 
In view of the role of GM-CSF,
 
 
 
TNF-
 
a
 
 and SCF in stimulat-
ing the differentiation of dendritic cells, including Langerhans
cells, from immature precursors, the questions arise whether
these cytokines are also relevant to maintain the differentiated
state of Langerhans cells within the epidermis and whether
they play any part in the further differentiation step that these
cells undergo upon leaving the epidermis. We have addressed
these issues in cultures of human epidermal sheets. We have
analysed by immunohistochemistry and morphometry both
the cells remaining within the epidermis and those migrated
into the culture medium, and have assessed the accessory activity
of the latter cells 
 
in vitro
 
.
 
Material and methods
 
Epidermal sheets and isolated cells
 
Human epidermal sheets were obtained at plastic surgery from
keratomes of normal, sun-unexposed human skin, in accord-
ance with Italian law and the ethical standards of the Helsinki
declaration. The epidermis was separated from the dermis with
dispase (grade II; Boehringer Mannheim, Mannheim, Germany).
Fresh cell suspension was obtained incubating the epidermis
with trypsin for 1 h and was analysed by flow cytometry.
Langerhans cells were obtained as described,
 
19
 
 briefly: the
epidermal sheets were further cut into pieces of about 15 mm
 
2
 
and placed into Petri dishes, floating on RPMI 1640 with the
addition of 10% fetal calf serum, 10 U/mL penicillin, 10 mg/mL
streptomycin and 50 mg/mL amphotericin B (all reagents for
the culture medium were from Seromed, Milan, Italy); the
cultures were incubated for 48 h at 37 
 
°
 
C in an atmosphere
of air and 5% CO
 
2
 
, in the following conditions: (i) with the
addition of TNF-
 
a
 
 (Pepro Tech, London, UK), 20 ng/mL;
(ii) with the addition of GM-CSF (Pepro Tech), 0.1 ng/mL;
(iii) with both TNF-
 
a
 
 and GM-CSF, each at the same concen-
tration as indicated above; (iv) with the addition of human
SCF (Pepro Tech) at concentrations of 1, 5 and 10 ng/mL;
(v) without any addition.
In preliminary experiments, doses of 40 and 80 ng/mL
TNF-
 
a
 
 and of 0.2 and 0.4 ng/mL GM-CSF were tested. As the
results were always the same, the lowest doses, as indicated above,
were used for the final experiments.
After 48 h the sheets were fixed in cold acetone for 10 min
and kept in 0.1 mol/L phosphate-buffered saline (PBS), pH 7.4,
calcium and magnesium free PBS, at 4 
 
°
 
C, until staining within
1 week.
The cells that migrated out of the sheets were collected from
the medium and analysed by flow cytometry or cytospinned
with the addition of 20% fetal calf serum to the culture
medium; the cytospins were fixed for 3 min in cold acetone and
stored at –20 
 
°
 
C until labelled.
 
Immunofluorescence
 
Spread epidermal sheets and cytospins were rehydrated,
blocked with 5% normal calf serum and incubated with
primary monoclonal antibodies (all from Immunotech,
Marseilles, France) against CD1a, CD 18 (common 
 
b
 
-chain of
the adhesion molecules: lymphocyte function-associated
antigen-1, Mac-1 and gp150,95), CD 54 (intercellular adhesion
molecule-1) and CD 80 (adhesion molecule B7-1). This incuba-
tion was protracted for 90 min at 37 
 
°
 
C, and was followed
by a fluorescein-isothiocyanate-conjugated goat antimouse
antibody (Sigma, Milan, Italy) for 1 h at 37 
 
°
 
C. The slides were
mounted with Gel/Mount (Biomeda, Foster City, California)
and observed in a Zeiss (Oberkochen, Germany) Axioskop
microscope equipped for epifluorescence.
To control for non-specific staining the appropriate isotype
controls were used. To identify Langerhans cells, cells were
double stained with HLA-DR and CD1a. All the incubations
were done at 4 
 
°
 
C for 30 min.
 
Morphometry
 
The number of CD1a-labelled cells/mm
 
2
 
 epidermis was
evaluated directly at the microscope, on at least 3 mm
 
2
 
 of
epidermis. To evaluate the effects of treatments on the size and
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shape of Langerhans cells, photomicrographs were taken of
sheets labelled with CD1a and printed at final magnification
 
·
 
 400. The profiles of immunostained cells were traced on a
transparency that was overlaid on photomicrographs, and cap-
tured into a Macintosh Performa 6300 by a Color OneScanner
600/27 (Apple Computer, Cupertino, CA, USA); the area and
perimeter of each cell profile were measured with Image 1.4
software (National Institute of Health, Bethesda, MD, USA).
These parameters of cell profiles are directly correlated, respect-
ively, to the volume and surface area of cells themselves.
 
20
 
Electron microscopy
 
Electron microscopy was used to check that the enzymatic
action of dispase did not alter basal keratinocytes and that cells
migrated out of the sheets had the ultrastructural features of
Langerhans cells. Therefore, in some experiments the sheets
and migrated cells were fixed with a mixture of 2% formaldehyde
and 2.5% glutaraldehyde in 0.1% mol/L cacodylate buffer,
pH 7.4, at room temperature, osmicated and embedded in
Epon 812. One micron thick sections were stained with toluidine
blue and observed by light microscopy; 70 nm thick sections
were stained with uranyl acetate, followed by bismuth tartrate
or lead citrate and observed in a Siemens (Munich, Germany)
102 electron microscope, at 80 kV.
 
Flow cytometry analysis
 
Cells suspended from freshly prepared epidermis and cells
collected from the medium after 48 h culture were stained and
analysed with a FACS Calibur (Becton Dickinson Mountain
view, CA). Antibody dilution and washing steps were done
in PBS containing 2% fetal calf serum then 1 
 
·
 
 10
 
5
 
 cells per
reaction were stained with the following monoclonal antibodies
at 10 
 
m
 
g /mL: CD1a phycoetythrin from Dako (Glostrup,
Denmark) and HLA-DR fluorescein isothiocyanate from Becton
Dickinson (Mountain View, CA, USA). In order to block Fc-
mediated unspecific binding, cells were incubated with fetal calf
serum and PBS (1 : 1) for 30 min at 4 
 
°
 
C. To control for non-
specific staining the appropriate isotype controls were used.
Langerhans cells were identified by double staining with HLA-
Dr and CD1a. All incubations were done at 4 
 
°
 
C for 30 min.
 
Allogeneic mixed leucocyte reaction
 
Allogeneic, responder T lymphocytes were isolated from human
peripheral blood of healthy donors, on a Lymphoprep gradient.
The cells at the interface were collected and washed in PBS;
three consecutive cycles of separation, collection and washing
were performed. The last wash was in RPMI medium. The cells
were counted, adjusted to 5 
 
·
 
 10
 
6
 
 per mL and cultured for
90 min in Petri dishes at 37 
 
°
 
C with 5% CO
 
2
 
. The non-adherent
cells were harvested and more than 95% were pure T cells; they
were washed for three consecutive passages in warm RPMI and
counted again. They were cocultured with Langerhans cells,
migrated out of the sheets within 48 h with or without cyto-
kines, after a purification of these latter cells on Lymphoprep
gradient (ICN Biomedicals, Aurora, OH, USA). For these experi-
ments, GM-CSF and TNF-
 
a
 
 were used at the concentrations
indicated above and SCF at concentration 5 ng/mL. Langerhans
cells were incubated with cytokines only during migration from
the epidermis, i.e. before admixing with lymphocytes; no
cytokine was added during mixed leucocyte reaction. The
responder T cells and the stimulator Langerhans cells, in
number of 9000 and 900, respectively, per well, were cocultured
for 6 days in round-bottomed 96 wells microtitre plates (Nunc,
Roskilde, Denmark). They were incubated in a total volume of
200 mL RPMI with 10% fetal calf serum. After 6 days coculture,
the cells were pulsed with [
 
3
 
H]thymidine (25 Ci/mmol, 1 mCi
per well; Amersham International, Amersham, U.K.). The cells
were then collected in a cell harvester and the incorporation of
the isotope was measured in a liquid scintillation counter and
expressed as the average count per minute of a triplicate.
 
Statistics
 
Data were subjected to analysis of variance. When this gave
significant results, couples of values were further analysed with
Student’s 
 
t
 
-test for paired values. 
 
P 
 
< 0.05 was assumed as
significant in all cases. Results are given as mean ± SD.
 
Results
 
Epidermal sheets
 
Epidermal sheets were well preserved upon separation from the
dermis and after 48 h culture as well. The number of CD1a-
positive dendritic cells, i.e. Langerhans cells within the sheets
was 392 
 
–
 
 62 per mm
 
2
 
 (mean 
 
–
 
 SD of three experiments) at
the onset of culture and decreased insignificantly with time
(290 
 
–
 
 127 per mm
 
2
 
 upon 48 h without cytokines; results of
three experiments). No treatment with cytokines affected
significantly the number of Langerhans cells (data not shown).
The number and length of dendrites also decreased with time in
untreated sheets and this led to a decrease in the surface area
and perimeter of Langerhans cells that was prevented at various
extents by GM-CSF and TNF-
 
a
 
, even more with the cytokines
together (fig. 1). However, the differences in cell area among
experimental conditions were not shown to be significant by
analysis of variance (fig. 2), whereas the differences in cell
perimeter were shown to be significant (
 
P 
 
< 0.05) and hence
were further analysed in pairs (one-tailed test). This identified
that the decrease during culture without cytokines was
significant (
 
P 
 
< 0.05) and that only a combined treatment with
GM-CSF and TNF-
 
a
 
 gave significantly better results (
 
P 
 
< 0.05)
than no treatment at all (fig. 3). CD1a antigen was expressed
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with similar intensity, at all times and in all experimental
conditions. The adhesion molecules CD18, CD54 and CD80
were not expressed in unstimulated sheets, either at the onset of
culture or 48 h later. The expression of CD18 by Langerhans
cells in the epidermis was induced by GM-CSF and TNF-
 
a
 
,
either alone or associated with each other, whereas the
expression of CD54 was stimulated by human SCF at higher
doses, more precisely at 5 ng/mL in some cells and at 10 ng/mL
in virtually all cells (Table 1).
 
Cells migrated into the culture medium
 
The vast majority of cells migrated out of the sheets and
collected from the culture medium were Langerhans cells, as
shown by CD1a staining analysed by fluorescence micro-
scopy, electron microscopy and flow cytometry (figs 4, 5, 6b).
Interestingly Langerhans cells migrated into the medium,
although still CD1a positive, downregulated the intensity of
CD1a expression if compared with the fresh cells (fig. 6a). The
shape, adhesive properties and antigen expression of these cells
were influenced by GM-CSF and TNF-
 
a
 
, but not by human
SCF at any dosage (Table 1). In particular, the cells in the
medium expressed CD18 in the presence of GM-CSF or
fig. 1 Langerhans cells were well preserved in freshly prepared epidermal
sheets (left panel). The dendrites became shorter and less branched upon
48 h culture without added cytokines (central panel); these alterations
were prevented by adding granulocyte-macrophage colony-stimulating
factor (0.1 ng/mL) and tumour necrosis factor-a  (20 ng/mL) to the culture
medium (right panel). Indirect immunofluorescence for CD1a; scale bar,
15 m m.
fig. 2 The surface area of CD1a cells in spread epidermal sheets is an estim-
ate of the cell volume. It was reduced upon culture and this reduction was
prevented by the addition of cytokines to the culture medium. However, the
differences among experimental conditions were not significant. Experi-
mental conditions were as follows: (A) start of culture; (B) 48 h culture without
cytokines; (C) 48 h culture with granulocyte-macrophage colony-stimulating
factor (GM-CSF) (0.1 ng/mL); (D) 48 h culture with GM-CSF (0.1 ng/mL) and
tumour necrosis factor (TNF)-a  (20 ng/mL); (E) 48 h culture with TNF-a
(20 ng/mL).
fig. 3 The perimeter of CD1a cells in spread epidermal sheets is an estimate
of the cell surface area and hence of dendriticity. It was reduced signific-
antly upon 48 h culture without cytokines (P < 0.05) and upon culture with
granulocyte-macrophage colony-stimulating factor (GM-CSF) (0.1 ng/mL) or
tumour necrosis factor (TNF)-a  (20 ng/mL). This reduction was prevented by
the addition of both GM-CSF and TNF-a  to cultures, so that the cell perimeter
in these conditions was significantly different from that upon culture without
cytokines or with either cytokine alone (P < 0.05), but not significantly dif-
ferent from that at the start of culture. Experimental conditions are labelled
as in fig. 2.
fig. 4 Cells migrated out of epidermal sheets during culture had a dendritic
shape, were rich in organelles and contained Birbeck granules (inset), i.e. the
marker of Langerhans cells. Electron microscopy; scale bar, 330 nm (130 nm
for the inset).
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TNF-
 
a
 
; furthermore, they aggregated into large clusters and
expressed CD54 in the presence of TNF-
 
a
 
 (fig. 5).
 
Allogeneic mixed leucocyte reaction
 
The Langerhans cells migrated out of the sheets within 48 h
culture maintained their functional activity of stimulating
the proliferation of T lymphocytes in a mixed leucocyte
reaction. The cells isolated from cultures treated with
cytokines were all significantly stronger stimulators of
lymphocyte proliferation than those isolated from control
cultures not treated with cytokines (
 
P 
 
< 0.05; two-tailed test).
Among cytokines, GM-CSF provided the greatest enhance-
ment of the accessory activity of Langerhans cells; however,
the differences among cytokines in this respect were not
significant (fig. 7).
 
Discussion
 
In this paper we have shown the following:
1 A combination of GM-CSF and TNF-
 
a
 
 prevented the
shrinkage and loss of dendrites of human Langerhans cells in
cultured epidermal sheets.
2 GM-CSF and TNF-
 
a
 
, but not human SCF, stimulated
the expression of CD18 containing adhesion receptors by
Langerhans cells in the sheets and by those migrated into the
culture medium.
3 The expression of intercellular adhesion molecule-1 by
Langerhans cells in the sheets was stimulated by human
SCF in a dose-dependent way and the expression of this
adhesion molecule by cells migrated into the culture medium
was stimulated only by TNF-
 
a
 
.
Table 1 Expression of membrane antigens by Langerhans cells in cultured epidermal sheets and by those migrated into the culture medium
Onset of 
culture
48 h culture
no cytokines GM-CSF TNF-a aaa GM-CSF + TNF-a aaa
hSCF
1 ng/mL 5 ng/mL 10 ng/mL
Epidermal sheets CD1a + + + + + + + +
CD18 - - + + + - - -
CD54 - - - - - - – +
CD80 - - - - - - - -
Migrated cells CD1a + + + + + + + +
CD18 - - + + + - - -
CD54 - - - + + - - -
CD80 - - - - - - - -
Human epidermal sheets were cultured in RPMI with 10% fetal calf serum, with or without cytokines as indicated. The concentration of GM-CSF was 0.1 ng/mL 
and that of TNF-a  20 ng/mL. After 48 h culture, the sheets and the cytospins of the cells migrated into the medium were analyzed by immunofluorescence. 
Positivity by all or by the vast majority of cells is indicated as +, positivity by a minority of cells is indicated as – . The total amount of cells that could be 
expected to be labeled with each antibody was estimated in sheets by the cells labeled for CD1a, and in cytospins by the total cells in the slide.
fig. 5 Cells migrated out of epidermal sheets during culture and analysed
in cytospins expressed CD1a and were isolated from each other upon
granulocyte-macrophage colony-stimulating factor (left panel) as well as in
unstimulated conditions. Upon tumour necrosis factor-a  (20 ng/mL) they
aggregated into clusters and expressed CD54, i.e. intercellular adhesion
molecule-1 (right panel). Indirect immunofluorescence for CD1a (left) and
CD54 (right); scale bar, 15 m m.
fig. 6 Flow cytometry analysis for HLA-DR and CD1a double-stained fresh
(a) and migrated Langerhans cells (b); in panel b the cells show down-
regulation of CD1a antigen, if compared with fresh ones (panel a), but this
antigen is still expressed by most cells.
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4 The Langerhans cells migrated into the culture medium were
potent accessory cells for allogeneic lymphocytes and this
activity was increased by GM-CSF, TNF- a  and human SCF.
5 The downregulation of CD1a by CD1a migrated out of
epidermal sheets within 48 h culture depends prevalently on
reduced expression of antigen by single cells, rather than on
a decrease in number of positive cells.
The association of GM-CSF and TNF-a  proved to be neces-
sary and effective to maintain fully developed dendrites to the
cells retained in the sheets. This indicates that apart from their
direct action in inducing the differentiation of immature pre-
cursors into Langerhans cells,2 these cytokines are effective in
maintaining a full-blown differentiated state of Langerhans
cells in the epidermis.
With the methods used in this study, CD18 appeared to be
not expressed by unstimulated Langerhans cells, either in the
epidermis or upon migration into the culture medium. On the
contrary, the expression of CD18 in both conditions was markedly
stimulated by GM-CSF and TNF-a  at the doses used in these
experiments. This molecule is part of adhesion receptors,
including the counter receptor for CD54, i.e. lymphocyte
function-associated antigen-1. The stimulation of CD18 expres-
sion was specific, as another cytokine, namely human SCF was
ineffective in this respect, whereas the latter cytokine influenced
the expression of another adhesion molecule, CD54. Previous
reports on the role of SCF on Langerhans cells differentiation
have stressed the influence of this cytokine on immature pre-
cursors, rather than on already differentiated cells, and all have
included preceding or contemporary treatment with other
cytokines besides SCF.4,5,17 Therefore, our finding that medium
to high doses of human SCF alone stimulate CD54 expression
by Langerhans cells in the epidermis cannot be compared with
previous reports and indicate that this cytokine can influence
fully differentiated Langerhans cells in the epidermis, although
only in a limited respect (i.e. CD54 expression). This finding
can represent the consequence of a direct influence of human
SCF on epidermal Langerhans cells. However, as only high
doses were effective and as Langerhans cells migrated into the
culture medium did not respond to SCF with expression of
CD54, an indirect effect mediated through keratinocytes can
be considered as an alternative explanation for our findings, as
keratinocytes express the receptor for SCF21 and can in turn
secrete cytokines stimulating Langerhans cells.22
The expression of CD54 by the cells migrated out of the
sheets only in the presence of TNF- a  suggests that this cytokine
stimulates a progression towards a further differentiation step
of Langerhans cells. This interpretation is based on the facts that
CD54 is expressed by Langerhans cells upon activation and is
necessary for stimulatory interactions with lymphocytes.7,23–25
A major finding of this study was that the stimulation of
Langerhans cells with TNF-a  is context sensitive. On one side, cells
free in the culture medium responded to TNF-a , either alone or
in association with GM-CSF, by increasing reciprocal stickiness
and expressing the adhesion molecule CD54, as already
described by others.26 On the other side, cells in the epidermis
responded to TNF-a  when it was associated with GM-CSF, by
maintaining well developed dendrites during culture. Keratino-
cytes could provide an inhibitory signal for the expression of
adhesion molecules in response to TNF- a  by secretion of
soluble molecules or by direct contact with Langerhans cells.
Keratinocytes can secrete several cytokines potentially affecting
Langerhans cells and interfering with TNF-a .22 Also, keratino-
cytes can establish contacts with Langerhans cells mediated by
E-cadherin27,28 and intercellular contacts can themselves influ-
ence the cell behaviour under several respects.29,30
The negativity for CD80 antigen of cells in the sheets and of
those in the medium contrasts with other data from the liter-
ature;31 however, in those experiments dendritic cells had been
obtained from immature precursors and had been treated
with TNF-a  for 24 h after having been stimulated with GM-CSF
and interleukin-4. Therefore, those data cannot be compared
strictly with ours, that indicate that 48 h stimulation with TNF-
a  are not enough to induce Langerhans cells from the human
epidermis to express CD80 upon leaving the epidermis itself
and migrating into a culture medium.
The results of mixed leucocyte reaction showed that the cells
harvested from the culture medium had accessory activity
towards T lymphocytes and this activity was stimulated by
exposure to cytokines before coculturing with lymphocytes.
During coculture, both Langerhans cells and lymphocytes
deliver each other signals through soluble and membrane
bound molecules, that stimulate both types of cells.24,32–34 This
might explain why Langerhans cells become potent accessory
fig. 7 The cells harvested from the culture medium were cocultured with all-
ogeneic lymphocytes and the proliferation of the latter cells was estimated
by the incorporation of [3H]thymidine as measured in a liquid scintillation
counter; the results are expressed as counts per minute (cpm). Lymphocytes
with no added cells were used as negative controls. The cells harvested from
untreated cultures stimulated lymphocyte proliferation significantly (P < 0.05).
Treatment with cytokines further increased significantly the stimulatory
capacity of harvested cells (P < 0.05). LC: Langerhans cells. Pretreatments of
Langerhans cells before coculture with lymphocytes, i.e. during migration from
epidermal sheets for 48 h, were as follows: (A) granulocyte-macrophage colony-
stimulating factor (GM-CSF) (0.1 ng/mL); (B) GM-CSF (0.1 ng/mL) and tumour
necrosis factor (TNF)-a  (20 ng/mL); (C) TNF-a  (20 ng/mL); (D) stem cell factor
(5 ng/mL).
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cells even in the absence of any previous treatment with
cytokines, as is well known from the literature.6,7,35 The
responses of the cells harvested from GM-CSF and TNF-a
treated media in this study are in line with what is known from
the literature for Langerhans cells.2,3 In addition, our results
indicate that SCF affects human Langerhans cells in their ability
to stimulate T lymphocytes, similar to TNF-a  and insignific-
antly less than GM-CSF; however, it did not influence the
morphology and immunophenotype of these cells as long as they
were in the culture medium without lymphocytes (at variance
with GM-CSF and TNF-a , which both induced the expression
of CD18 and, TNF-a , also induced the expression of CD54).
The effects of cytokine preincubation of Langerhans cells on
lymphocyte proliferation might depend on cytokines enhan-
cing the viability of Langerhans cells and preventing their
apoptosis,36,37 thus allowing for a higher number of stimulating
cells in mixed cultures.
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